Xiaochen Bo
Impact in
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- Single-cell and spatial transcriptomics
- Bioinformatics and Genomic Networks
- Genomics and Phylogenetic Studies
- Genomics and Chromatin Dynamics
- Cancer Research top 2%
Papers in
-
- Computational Drug Discovery Methods 16
-
- Bioinformatics and Genomic Networks 6
- Genomics and Phylogenetic Studies 4
- Single-cell and spatial transcriptomics 3
- Machine Learning in Bioinformatics 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Erqiang Hu (2 shared papers)Wenli Tang (2 shared papers)Tingze Feng (2 shared papers)Shuangbin Xu (2 shared papers)Guangchuang Yu (2 shared papers)Zehan Dai (2 shared papers)Lang Zhou (2 shared papers)Meijun Chen (2 shared papers)
- Journals
- Nature Communications (4 papers)Science China Life Sciences (3 papers)Briefings in Bioinformatics (2 papers)Advanced Science (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Xiaochen Bo
45 papers receiving 10.1k citations
Xiaochen Bo's Hit Papers
Peers
Comparison fields: 5 of 144
- Molecular Biology 3.6k
- Cancer Research 673
- Aging 81
- Oncology 939
- Immunology 660
Countries citing papers authored by Xiaochen Bo
This map shows the geographic impact of Xiaochen Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Bo more than expected).
Fields of papers citing papers by Xiaochen Bo
This network shows the impact of papers produced by Xiaochen Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Bo. The network helps show where Xiaochen Bo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Bo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | clusterProfiler 4.0: A universal enrichment tool for interpreting omics data Hit paper breakdown → | 2021 | 8757 |
| 2 | N6-Methyladenine DNA Modification in the Human Genome Hit paper breakdown → | 2018 | 429 |
| 3 | 2021 | 237 | |
| 4 | 2020 | 72 | |
| 5 | 2023 | 66 | |
| 6 | 2018 | 52 | |
| 7 | 2022 | 48 | |
| 8 | 2024 | 48 | |
| 9 | 2024 | 48 | |
| 10 | 2020 | 34 | |
| 11 | 2024 | 34 | |
| 12 | 2021 | 32 | |
| 13 | 2021 | 32 | |
| 14 | 2020 | 28 | |
| 15 | 2025 | 28 | |
| 16 | 2018 | 23 | |
| 17 | 2025 | 23 | |
| 18 | 2021 | 22 | |
| 19 | 2022 | 22 | |
| 20 | 2022 | 20 |
About Xiaochen Bo
Xiaochen Bo is a scholar working on Computational Theory and Mathematics, Molecular Biology, Cancer Research, Genetics and Infectious Diseases, having authored 50 papers that have together received 10.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (16 papers), Bioinformatics and Genomic Networks (6 papers), Genomics and Phylogenetic Studies (4 papers), Single-cell and spatial transcriptomics (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer-related molecular mechanisms research (2 papers), Machine Learning in Bioinformatics (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Molecular Biology (3.6k citations), Cancer Research (673 citations), Aging (81 citations), Oncology (939 citations) and Immunology (660 citations). Xiaochen Bo has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Erqiang Hu, Wenli Tang, Tingze Feng, Shuangbin Xu, Guangchuang Yu, Zehan Dai, Lang Zhou, Meijun Chen, Tianzhi Wu and Li Zhan. Their work appears in journals such as Nature Communications, Science China Life Sciences, Briefings in Bioinformatics, Advanced Science and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.